| Authors: |
Mhlanga FG; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe. Electronic address: fmhlanga@uz-ctrc.org., Szydlo DW; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, WA, USA., Mayo AJ; FHI 360, Durham, NC, USA., Bunge K; University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, PA, USA., Fairlie L; Maternal and Child Health, Wits Reproductive Health and HIV Institute, Johannesburg, South Africa., Nakabiito C; Makerere University-Johns Hopkins University, Kampala, Uganda., Musara P; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Mgodi NM; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Dadabhai S; Johns Hopkins Research Project-Kamuzu University of Health Sciences, Blantyre, Malawi., Scheckter R; FHI 360, Durham, NC, USA., Anderson PL; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Marzinke MA; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Chappell C; University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, PA, USA., Gadama LA; Johns Hopkins Research Project-Kamuzu University of Health Sciences, Blantyre, Malawi., Richardson BA; Department of Biostatistics and Department of Global Health, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Piper JM; DAIDS/NIAID/NIH/HHS, Rockville, ML, USA., Hillier SL; University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, PA, USA. |
